BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12882875)

  • 1. Heart failure: the frequent, forgotten, and often fatal complication of diabetes.
    Bell DS
    Diabetes Care; 2003 Aug; 26(8):2433-41. PubMed ID: 12882875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus, left ventricular dysfunction and congestive heart failure].
    Tarantini L; Di Lenarda A; Velussi M; Faggiano P; Comaschi M; Faglia E; Maggioni AP
    Ital Heart J Suppl; 2004 Aug; 5(8):605-15. PubMed ID: 15554015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congestive heart failure and diabetes mellitus].
    Ancion A; Lancellotti P; PiƩrard LA
    Rev Med Liege; 2005; 60(5-6):536-40. PubMed ID: 16035323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers and heart failure.
    Cruickshank JM
    Indian Heart J; 2010; 62(2):101-10. PubMed ID: 21180298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of heart failure.
    Cohn JN
    Cardiology; 1999; 92 Suppl 1():22-5; discussion 26-8. PubMed ID: 10652968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction.
    Carrabba N; Valenti R; Parodi G; Santoro GM; Antoniucci D
    Circulation; 2004 Oct; 110(14):1974-9. PubMed ID: 15451792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
    Tsutsui H; Matsushima S; Kinugawa S; Ide T; Inoue N; Ohta Y; Yokota T; Hamaguchi S; Sunagawa K
    Hypertens Res; 2007 May; 30(5):439-49. PubMed ID: 17587756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure after myocardial infarction: diagnosis, treatment, prevention. Echocardiography should be a routine procedure in myocardial infarction].
    Willenheimer R; Erhardt L; Eskilsson J
    Lakartidningen; 1998 Jul; 95(28-29):3183-7. PubMed ID: 9700263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure.
    Genovesi Ebert A; Colivicchi F; Malvezzi Caracciolo M; Riccio C
    Monaldi Arch Chest Dis; 2009 Mar; 72(1):18-22. PubMed ID: 19645208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring new treatment strategies in heart failure.
    Swedberg K
    Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of heart failure in patients with diabetes: clinical update.
    Bell DS
    Ethn Dis; 2002; 12(1):S1-12-8. PubMed ID: 11915848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.